U.S. Pauses Johnson & Johnson Vaccine Following Six Cases of Rare Blood Clotting 2021-04-14

Published: April 14, 2021, 4 p.m.

U.S. Pauses Johnson & Johnson Vaccine Following Six Cases of Rare Blood Clotting

Federal health agencies will investigate Johnson & Johnson's potential link to the rare blood clotting disorder “out of an abundance of caution.”

How the Federal Government Can Effectively Distribute Tribal Stimulus Funding

Advocates are hoping the $32 billion in stimulus funding to Native communities can help with current disparities, but also address longstanding issues of underfunding for Indian Country.

Pam Chatman, founder of Boss Lady Workforce Transportation, on How She's Getting Vaccines to the People of Mississippi

With so many people in red states hesitant to take the COVID-19 vaccine, one woman is working in the state of Mississippi to help get shots in arms.   

How the Media is Reporting on the Pause of the Johnson & Johnson Vaccine

What impact could reporting on the pause of the Johnson and Johnson vaccine have on vaccine hesitancy?